Emergent Health Corp. Reports First Quarter 2011 Financial and Business Progress

Emergent Health Corp. (the "Company") (Pink Sheets:EMGE) is pleased to update its historic unaudited financial statements and Management's Discussion and Analysis of Financial Condition for first quarter of 2011 compared to first quarter of 2010.

First quarter unaudited revenues for January 1, 2011 to March 31, 2011 were $71,296.62 compared to $53,853.11 for January 1 to March 31, 2010. This is an approximate 32% increase. The Company attributes this to increased International demand for new products, and while no guarantee it will continue, efforts in these markets continue.

Net profit unaudited before taxes for the same periods January 1, 2011 to March 31, 2011 were $30,383.33 compared to $16,260.32 for the period January 1, 2010 to March 31, 2010. This is an approximate 87% increase and is attributed to tight cost control. These margins could decrease due to possible need for additional staff in the future.

The Company's total assets as of March 31, 2011 were $435,000.00 compared to $378,081.00 as of March 31, 2010. The Company's cash position was $405,556.00 as of March 31, 2011 compared to $362,101.00 as of March 31, 2010.

The Company continues to have no long term debt and believes it is adequately funded for the balance of this year. For complete reporting purposes, the Company presents its most recent Balance Sheet and Operating Statement as of March 31, 2011: http://emergenthealth.com/docs/Emergent Balance Sheet March, 31, 2011.pdf http://emergenthealth.com/docs/Emergent Statement of Operations Jan 1 to March 31, 2011.pdf

The Company continues to successfully market its revolutionary new MultiVitamin-MultiMineral with Stem Cell Nutrition Support. Details are at the JDI™ Division website http://jdimlm.com or here http://stemcellbook.com

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. With patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.

Sign up for Free Newsletter Updates here: http://emergenthealth.com

This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

CONTACT: IR Contact
         866-427-6143